As people grow older and nutrients, sunlight, influence of environmental factors, human synthesis of hyaluronic acid (Restylane) decreasing capacity HA, hyaluronic acid in the skin (hyaluronic acid) may decrease the content of HA, in the embryonic stages of hyaluronic acid in the body (hyaluronic acid) HA the highest decrease after birth. When 20 year old body's hyaluronic acid (Restylane) relative content positioning 100% HA, 30, 50, 60 years old respectively, and 65%, and 25%. When hyaluronic acid in the skin (hyaluronic acid) HA content falls below a certain level, the layer of skin moisture content decreases, causing aging stratum corneum, skin becomes rough, wrinkles, loss of elasticity, is aging, this phenomenon generally occurs after the age of 25. This is the gap between older people and children's skin is one of the main reasons. While hyaluronic acid in the skin (hyaluronic acid) HA damage associated with UV, so long engaged in field operations, Highland life, outdoors than an indoor staff of the skin is rough.
Double-blind human clinical trials show that after oral administration of 4 hour, hyaluronic acid content in the blood significantly increased peak 12-hour, 70 times higher than the control group. Even served 7 days to reach stable concentration.
-
singclean | 2016-04-13
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2016-04-13
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2016-04-13
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling